Nantahala Capital Management LLC 13D and 13G filings for Cidara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:51 pm Sale | 2023-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | Nantahala Capital Management LLC | 77,337 1.700% | -141,036 (-64.58%) | Filing |
| 2023-02-14 4:58 pm Sale | 2022-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | Nantahala Capital Management LLC | 218,373 6.100% | -45,150 (-17.13%) | Filing |
| 2022-02-14 08:30 am Purchase | 2021-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | Nantahala Capital Management LLC | 263,523 7.900% | 263,523 (New Position) | Filing |